What STRmix does

STRmix Limited, a wholly owned subsidiary of New Zealand government-owned research institute PHF Science (formerly ESR), develops probabilistic genotyping software for forensic DNA interpretation. Its flagship product, STRmix, applies Markov Chain Monte Carlo (MCMC) methods to resolve complex mixed DNA profiles that were previously considered too complex to interpret, generating likelihood ratios that quantify the strength of evidence. The product suite includes STRmix (core deconvolution and LR calculation), FaSTR DNA (raw data preprocessing), DBLR (high-speed database searching), and STRmix NGS (a version built for Next Generation Sequencing workflows). Algorithms have been co-developed with Forensic Science SA in Australia and validated by the FBI for mixtures of up to five contributors.

The company serves government forensic laboratories, law enforcement agencies, and academic forensic science programs across more than 30 countries, with 96+ U.S. organizations and 120+ laboratories worldwide having adopted the software. Since introduction in 2012, STRmix outputs have been used in over 700,000 criminal cases and cited in 3,600+ court presentations, with 40+ successful admissibility hearings in U.S. jurisdictions. Distribution is hybrid: direct sales in the UK, Europe, and Rest of World, with NicheVision Forensics as the exclusive distributor for the Americas.

Revenue is generated primarily through enterprise software licensing to government laboratories, supplemented by paid training workshops (4-day full user workshops at $3,600 per participant, 1-day NGS early adopter workshops at $750 per participant). The customer base is concentrated entirely in the public-sector forensic vertical, with the software deployed as standard infrastructure for agencies including the FBI, ATF, U.S. Army Criminal Investigation Laboratory, and multiple U.S. state crime labs. ISO 9001:2015 certification (2025) and ongoing major-version releases through v2.13 (October 2025) indicate continued product investment despite the company operating with only 1-10 direct employees, supported by parent-organization R&D resources.

Name

STRmix

Legal name

STRmix Limited

Website

https://strmix.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

STRmix develops MCMC-based probabilistic genotyping software that interprets complex mixed DNA profiles for government forensic laboratories and law enforcement agencies in 30+ countries.

Ownership category

akta.pro rank

Product category

Forensic DNA Software

NAICS

Medical Laboratories (621511), Software Publishers (5132), Scientific Research and Development Services (5417)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

akta.pro secondary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

• Forensic DNA software
• Probabilistic genotyping
• Mixed DNA interpretation
• Likelihood ratio analysis
• DNA database search

Headquarters

HQ city

Akron

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Software Licensing: STRmix forensic DNA software is licensed to forensic laboratories for use in criminal casework. The software requires validation and training before deployment.
2. Training Workshops: STRmix provides paid training workshops for users. Full user workshops cost $3,600 per participant (4-day event), while early adopter NGS workshops cost $750 per participant (1-day event).

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

STRmix develops and licenses probabilistic genotyping software that enables forensic laboratories to interpret complex mixed DNA profiles and calculate likelihood ratios using Markov Chain Monte Carlo (MCMC) methods. Its product suite includes STRmix™ (core probabilistic genotyping), FaSTR™ DNA (automated profile analysis), DBLR™ (high-speed database searching), and STRmix™ NGS (Next Generation Sequencing profiles), complemented by paid training workshops.

Product overview

STRmix offers a suite of forensic DNA software products. The flagship product, STRmix™, is a probabilistic genotyping application that resolves complex mixed DNA profiles through continuous model interpretation and likelihood ratio calculation. STRmix works alongside FaSTR™ DNA (which provides automated DNA profile analysis and data preparation) and DBLR™ (which enables rapid database searching with millions of likelihood ratio calculations) to form an end-to-end analysis and interpretation workflow. STRmix™ NGS extends the suite to Next Generation Sequencing (NGS) profiles. Together these products serve forensic laboratories worldwide for criminal casework interpretation.

Differentiator

Problem solved

Functional benefit

Brands

• FaSTR DNA: DNA analysis platform that provides end-to-end analysis solution when used with STRmix.
• DBLR
• STRmix NGS

Products and services

• STRmix™ Probabilistic genotyping software that uses Markov Chain Monte Carlo (MCMC) methods to resolve complex mixed DNA profiles in forensic casework, generating likelihood ratios to assess the strength of DNA evidence for use in criminal investigations. Sold to forensic laboratories and law enforcement agencies.
• FaSTR™ DNA

Quantifiable outcome

• Interpretable DNA rates in gun cases increased from ~40% to >70%
• +4 more outcomes

Named customers18 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature8 records

Partnerships

Four partnerships are on record, tiered minor and core.

• Dr. Jack BallantyneminorOthers · 17 February 2026Dr. Jack Ballantyne, Director of the National Center for Forensic Science and Professor at the University of Central Florida, joined the STRmix Advisory Board as an unpaid member providing independent, non-binding advice on business challenges including environmental scanning, market strategies, and general strategy.
• NicheVision Inc.coreChannel Partner/ Reseller/ Distributor · 6 October 2014NicheVision Forensics is the exclusive STRmix distributor for the Americas, including the United States, Canada, Central and South America. NicheVision brings forensic software market knowledge and strong technical capability to help bring STRmix to labs seeking to resolve mixed DNA samples.
• PHF Science (formerly ESR)coreStrategic or Co-development PartnerPHF Science is a New Zealand Government-owned research organization that is the parent company of STRmix Limited. PHF Science delivers world-class research, knowledge, and laboratory services, and developed STRmix in collaboration with Forensic Science SA.
• Forensic Science SA (FSSA)coreStrategic or Co-development PartnerForensic Science SA provides independent, expert scientific evidence to the justice system and is credited with co-developing STRmix alongside PHF Science. FSSA Director Chris Pearman noted STRmix has greatly assisted in providing high-quality evidentiary information to South Australia Police.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Promega: Promega manufactures STR amplification kits and provides GeneMarker HID software for forensic genotype analysis. It is an established forensic tools provider whose chemistry kits are typically used upstream of STRmix, making it a complementary but also potentially competitive ecosystem player.
• QIAGEN: QIAGEN provides forensic sample-to-software workflows including the QIAcube extraction platform and, via its Verogen acquisition, NGS-based human identification kits. It is a broad incumbent in forensic molecular biology that competes with STRmix indirectly through end-to-end solution positioning.
• Illumina: Illumina is the dominant NGS instrument and reagent provider, including for forensic sequencing applications via its MiSeq FGx and NextSeq platforms. While Illumina does not provide probabilistic genotyping directly, its ForenSeq ecosystem defines the upstream data standards that STRmix NGS must integrate with.
• Thermo Fisher Scientific: Thermo Fisher Scientific offers a broad human identification portfolio including PCR/CE instruments, kits, and analysis software used by forensic labs. While not a probabilistic genotyping specialist, its global scale, service network, and bundled offerings compete for the same procurement budgets as STRmix.

Others

• NicheVision Forensics: NicheVision Forensics is STRmix's exclusive distributor for North, South, and Central America, and also distributes complementary forensic DNA software. Although a partner rather than a competitor, NicheVision's channel position and own product offerings make it directly relevant to STRmix's go-to-market.
• Bode Cellmark Forensics: Bode Cellmark Forensics (a Bode Technology / LabCorp subsidiary) is a private forensic DNA laboratory customer of STRmix. While not a software competitor, it is representative of the private-lab customer segment and could develop or adopt in-house alternatives over time.

Emerging players

• Parabon NanoLabs: Parabon NanoLabs offers the Snapshot DNA Phenotyping and Genetic Genealogy services, including tools that analyze complex DNA mixtures. While focused on investigative genetic genealogy and phenotyping rather than probabilistic genotyping, it overlaps with STRmix in advanced forensic DNA interpretation services.

Direct peers

• DNA View: DNA View provides probabilistic genotyping software (such as likeLTD and BALM) for forensic DNA mixture interpretation. It competes with STRmix on statistical models and likelihood ratio approaches, particularly in academic and European forensic laboratory settings.
• Verogen: Verogen (acquired by QIAGEN) provides NGS-based forensic DNA workflows, including the ForenSeq DNA Signature Prep kit and analysis software. It is the leading NGS-native competitor and the primary strategic threat to STRmix's CE-based installed base as labs transition to sequencing.
• Cybergenetics: Cybergenetics develops TrueAllele, a competing probabilistic genotyping system for forensic DNA mixture interpretation using MCMC-style methods. It is the most direct head-to-head competitor to STRmix in U.S. and international forensic labs and competes for the same government procurement budgets.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about STRmix